Price $10.75 |
Market Cap
199.3M
|
Sector Health Care |
Div. Growth
-25.00%
|
|
P/E
-
|
P/B
1.51
|
P/S
0.6
|
Dividend %
3.80%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-3.7K
|
FCF
-1.2
|
|
Op. Margin
1.70%
|
Net Margin
-0.20%
|
ROE
-0.40%
|
ROI
1.10%
|
|
ROA
-0.30%
|
EPS Growth
-104.80%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| DURECT Corporation (DRRX) | $1.73 | - | - | 233.7M | Strong Buy |
| Digirad Corporation (DRAD) | $3.40 | - | 6.30% | 70.9M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.35 | - | - | 3.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
